Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database: A Disproportionality Analysis

By Shamloo Behrooz K.  

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 507-518

Adis International

Access to resources Recommend Favorite

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei  

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite

Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database

By Motola Domenico  

Drug Safety, Vol. 35, Iss. 4, 2012-04 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants

By Ehrenpreis Eli D   Sifuentes Humberto   Ehrenpreis Jamie E   Smith Zachary L   Marshall Mike L  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 177-183

Informa Healthcare

Access to resources Recommend Favorite

Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System: Disposition of Events Identified and Impact on Product Safety Profiles

By Bailey Steven   Singh Ajay   Azadian Robert   Huber Peter   Blum Michael  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite